Subcutaneous (SubQ) injection delivers a research compound into the fatty tissue layer directly beneath the skin — below the dermis but above the muscle. For most research peptides, this is the standard administration route: it provides consistent absorption, avoids major blood vessels, uses the smallest possible needles, and can be performed with minimal tissue trauma under correct sterile technique.
This guide is specific to in vitro and in vivo laboratory research applications. The technique described here reflects established subcutaneous injection protocol as used in preclinical research settings. See the peptide reconstitution guide for preparation steps before injection, and the storage guide for handling before and after use.
All protocols described here are for in vitro and in vivo laboratory research use only. Evo Peptides compounds are not approved for human consumption, therapeutic use, or veterinary application. Researchers must comply with all applicable institutional, local, state, and federal regulations.
Supplies Checklist
Prepare all supplies before beginning. Incomplete setup is the leading cause of protocol deviations and sterility errors in research injection settings.
Dose Calculation Reference
Accurate dose math is the single most important pre-injection calculation. Errors here compound through every injection in a protocol. The formula is always the same: divide your target dose by your vial concentration.
Step-by-Step Injection Protocol
Follow this sequence without skipping steps. Each step exists for a specific sterility or accuracy reason.
-
1Wash hands and prepare workspaceWash with soap for at least 20 seconds. Clear and wipe down the work surface. Lay out all supplies before opening any sterile packaging. Never open syringes or swabs until immediately before use.Research NoteConsider nitrile gloves in shared lab environments or when working with multiple vials to prevent cross-contamination between samples.
-
2Inspect and warm the peptide vialRemove the reconstituted vial from refrigeration. Allow it to reach room temperature (5–10 minutes) — cold solution causes more discomfort and may affect absorption consistency. Inspect visually: solution should be clear (or the characteristic color of the compound — GHK-Cu is light blue). Cloudiness, particulates, or color change = discard.Do Not Use If: Solution is cloudy, contains visible particulates, shows unusual discoloration, or the vial has been open for more than 28 days. Refer to the storage guide for stability windows.
-
3Wipe vial stopper with alcohol swabSwab the rubber stopper of the peptide vial with a fresh 70% isopropyl alcohol swab. Allow to air-dry for 10–15 seconds before inserting any needle. Wet alcohol on the stopper can be carried into the vial on the needle tip.
-
4Calculate and draw the doseUsing your pre-calculated volume (see dose math section above): draw air into the syringe equal to your dose volume, insert the needle through the vial stopper, inject the air to equalize pressure, invert the vial, and slowly pull the plunger to draw your calculated volume. Check for air bubbles — tap and expel before withdrawing the needle from the vial.Precision TipPull 10–15% more than needed, then push back to exact volume — this eliminates air pockets and gives a clean meniscus reading at your target mark.
-
5Select injection site and clean with alcoholChoose the next site in your rotation sequence (see injection site map below). Swab the skin with a fresh alcohol swab in a circular motion from center outward. Allow to fully air-dry — 10–15 seconds minimum. Injecting through wet alcohol stings and increases local irritation.
-
6Pinch skin and insert needlePinch 1–2 inches of skin between thumb and forefinger to lift the subcutaneous layer away from underlying muscle. Insert the needle at 45° for lean subjects or 90° for subjects with more subcutaneous fat. Insert in a smooth, swift motion — hesitation increases discomfort.Depth CheckA 0.5 inch (12.7mm) needle at 45° in pinched skin reliably reaches subcutaneous tissue for most body compositions without penetrating muscle. This is the standard configuration for most research SubQ protocols.
-
7Depress plunger slowly — 5–10 secondsApply steady, even pressure to the plunger. Do not inject rapidly — rapid injection creates pressure that increases discomfort and can force solution into unintended tissue planes. 0.1 mL (10 units) over 5–10 seconds is the target pace for standard research doses.
-
8Wait 5 seconds, then withdrawAfter the plunger is fully depressed, maintain needle position for 5 seconds. This allows the solution to begin dispersing into surrounding tissue and reduces the chance of solution tracking back through the needle channel on withdrawal.
-
9Withdraw and disposeWithdraw the needle smoothly in the same angle as insertion. Apply gentle pressure with a clean swab if any bleeding occurs — do not rub, which disperses solution and increases bruising. Immediately dispose of the needle in a puncture-resistant sharps container. Never recap with two hands or leave uncapped on the bench.
-
10Document in research logRecord: date/time, peptide compound and batch number, vial concentration, volume drawn, calculated dose, injection site used, and any observations (mild redness, reaction, etc.). Consistent documentation is required for research reproducibility and protocol integrity.Rotation RecordTracking injection sites in your log is the simplest way to enforce systematic rotation and prevent lipohypertrophy at frequently used sites.
Injection Sites & Rotation Map
Site selection and systematic rotation are as important as sterile technique. Repeated injection at any single site causes lipohypertrophy — hardened fatty tissue that absorbs compounds inconsistently, introducing variables that compromise research data.
SubQ vs IM vs IV — Route Comparison
Most research peptide protocols use subcutaneous injection. Understanding why, and when other routes are used, helps researchers interpret published preclinical data correctly — since some studies use IP (intraperitoneal) or IV routes that affect pharmacokinetics.
| Route | Depth | Absorption | Onset | Common For | Notes |
|---|---|---|---|---|---|
| Subcutaneous (SubQ) | Fat layer, 4–10mm | Moderate, consistent | 15–60 min to Cmax | BPC-157, TB-500, GHK-Cu, GLP analogs | Standard for most peptides; extends apparent t½ vs IV |
| Intramuscular (IM) | Muscle, 12–25mm | Faster than SubQ | 5–30 min to Cmax | Some vaccine-type studies; rarely needed for peptides | More painful; larger needles; generally unnecessary for peptides |
| Intravenous (IV) | Bloodstream direct | Immediate (100%) | Seconds to Cmax | PK studies; precise t½ measurement | Shortest measured t½; requires sterile technique; not practical outside lab |
| Intraperitoneal (IP) | Peritoneal cavity | Very fast (near IV) | Minutes to Cmax | Rodent model research (NOT used in humans) | Common in preclinical mouse/rat studies; explains some shorter-acting protocol data |
| Intranasal | Nasal mucosa | Partial (10–50%) | 5–20 min | Selank, Semax, some neuropeptides | CNS-targeting; bypasses GI; highly compound-specific; lower bioavailability |
| Oral | GI tract | Near zero (unmodified) | N/A for most | BPC-157 GI models only | Peptides destroyed by GI proteases; oral BPC-157 data specific to gut endpoints |
Most Common Injection Errors
- Injecting through wet alcohol. The swab must air-dry 10–15 seconds. Wet alcohol is carried into the tissue by the needle, increasing local irritation.
- Rapid plunger depression. Injecting the full volume in under 2 seconds creates pressure and pain. Five to ten seconds is the target for standard research doses.
- Not warming the vial before injection. Cold solution from the refrigerator causes more discomfort and may affect local tissue response. 5 minutes at room temperature is sufficient.
- No site rotation record. Without documentation, site rotation becomes approximate. Systematic logging prevents repeated use of the same site across consecutive injections.
- Reusing syringes. A used needle becomes dull after a single use, significantly increasing insertion force and tissue trauma on subsequent injections.
- Dose calculation from wrong concentration. If the reconstitution volume was changed from the standard protocol, the concentration changes. Always verify concentration before calculating volume.
- Injecting into the wrong layer. Injecting too shallowly (intradermal) produces a visible raised wheal. Too deep (IM) changes absorption kinetics and may increase discomfort. Consistent angle and pinch technique prevents both.
- Rubbing the injection site. Rubbing after withdrawal disperses the solution across a wider tissue area and can increase bruising. Gentle pressure only.
Injection Site Reactions — Reference Table
| Observation | Expected? | Cause | Action |
|---|---|---|---|
| Mild redness, 1–2 cm around site | Normal | Local inflammatory response to needle | Document; resolve within 1–2 hours |
| Minor swelling, slight tenderness | Normal | Normal tissue response | No action needed; resolves within hours |
| Small drop of blood on withdrawal | Normal | Minor capillary nick | Gentle pressure with clean swab; do not rub |
| Visible wheal (raised bump under skin) | Technique issue | Intradermal injection — too shallow | Note in log; adjust angle/depth next injection |
| Hard lump persisting 24–48h | Monitor | Early lipohypertrophy or hematoma | Do not inject that site again until resolved; rotate away |
| Persistent large bruising | Monitor | Capillary disruption; needle too large or rapid injection | Review technique; consider finer gauge; document |
| Warmth, expanding redness, swelling after 24h | Concerning | Possible infection / sterility breach | Discontinue injections at that site; full protocol review |
| Systemic reaction (hives, difficulty breathing) | Serious | Allergic reaction (rare with research peptides) | Immediate protocol cessation; emergency response per institutional protocol |